Cardiovascular outcomes and LDL-cholesterol levels in EMPA-REG OUTCOME®:

Objective:It is well established that higher low-density lipoprotein (LDL)-cholesterol levels are associated with increased cardiovascular risk. We analyzed whether effects of empagliflozin on card...